Gammaked Background

GammakedTM is an IG (immune globulin) therapy and FDA approved for the treatment of chronic inflammatory demyelinating polyneuropathy (CIDP), primary immunodeficiency (PI) and idiopathic thrombocytopenic purpura (ITP). Gammaked routes of administration include intravenous and subcutaneous delivery. The intravenous delivery mode is approved to treat CIDP, PI and ITP, while the subcutaneous delivery mode is approved to treat only PI.

Take Care With Gammaked

FOR PATIENTS

Take Care With GAMMAKEDTM  Enter Site »

FOR HEALTHCARE PROVIDERS

GAMMAKEDTM is a sucrose-free 10% IGIV Solution Enter Site »